AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Ex vivo stimulation of cytomegalovirus (CMV)-specific T cells was accomplished using CMV pp65-modified dendritic cells as stimulators.
"Cytomegalovirus (CMV) infection is a dangerous complication in immunosuppressed individuals such as allogeneic stem cell transplant patients. CMV disease can be prevented by the early post-transplant transfer of donor-derived, CMV-directed, T cells. Fast and cost efficient methods to generate CMV-specific T cells are, therefore, warranted," scientists in Sweden report.
"The current study utilized peptide-pulsed and adenovirus-transduced dendritic cells (DC) to generate CMV-restricted T cells," stated Bjorn Carlsson and colleagues at the University of Uppsala. "After one stimulation with CMV pp65[subscript]495-503 peptide-pulsed DC and three re-stimulations with peptide-pulsed monocytes, virtually all T cells were CD8+, expressed the relevant T cell receptor, and exhibited high peptide-specific lytic activity. After only one stimulation, pp65[subscript]495-503-restricted T cells could be sorted to a purity of higher than 95% and expanded up to 1000-fold in 2 weeks. This technique may prove useful for the rapid generation of large quantities of specific cytolytic T lymphocytes (CTL) for cell therapy."
"DC transduced with an adenoviral vector encoding the full-length pp65 ...